| Literature DB >> 29248428 |
Ming-Cheng Chang1, Yu-Li Chen2, Han-Wei Lin3, Ying-Cheng Chiang2, Chi-Fang Chang2, Shu-Feng Hsieh2, Chi-An Chen2, Wei-Zen Sun4, Wen-Fang Cheng5.
Abstract
Ionizing radiation therapy is a well-established method of eradicating locally advanced tumors. Here, we examined whether local RT enhanced the potency of an antigen-specific DNA vaccine, and we investigated the possible underlying mechanism. Using the HPV16 E6/E7+ syngeneic TC-1 tumor, we evaluated the combination of CTGF/E7 vaccination with local irradiation with regard to synergistic antigen-specific immunity and anti-tumor effects. Tumor-bearing mice treated with local RT (6 Gy twice weekly) and CTGF/E7 DNA vaccination exhibited dramatically increased numbers of E7-specific CD8+ cytotoxic T cell precursors, higher titers of anti-E7 Abs, and significantly reduced tumor size. The combination of local RT and CTGF/E7 vaccination also elicited abscopal effects on non-irradiated local subcutaneous and distant pulmonary metastatic tumors. Local irradiation induced the expression of high-mobility group box 1 protein (HMGB-1) in apoptotic tumor cells and stimulated dendritic cell (DC) maturation, consequently inducing antigen-specific immune responses. Additionally, local irradiation eventually increased the effector-to-suppressor cell ratio in the tumor microenvironment. Overall, local irradiation enhanced the antigen-specific immunity and anti-tumor effects on local and distant metastatic tumors generated by an antigen-specific DNA vaccine. These findings suggest that the combination of irradiation with antigen-specific immunotherapy is a promising new clinical strategy for cancer therapy.Entities:
Keywords: DNA vaccine; HMGB-1; cancer immunotherapy; dendritic cell; radiation
Mesh:
Substances:
Year: 2017 PMID: 29248428 PMCID: PMC5835145 DOI: 10.1016/j.ymthe.2017.11.011
Source DB: PubMed Journal: Mol Ther ISSN: 1525-0016 Impact factor: 11.454